メインナビゲーションにスキップ 検索にスキップ メインコンテンツにスキップ

Development of a highly sensitive device for counting the number of disease-specific exosomes in human sera

  • Yasuaki Kabe
  • , Makoto Suematsu
  • , Satoshi Sakamoto
  • , Miwa Hirai
  • , Ikko Koike
  • , Takako Hishiki
  • , Atsushi Matsuda
  • , Yuichi Hasegawa
  • , Koji Tsujita
  • , Masayuki Ono
  • , Naoko Minegishi
  • , Atsushi Hozawa
  • , Yoshinori Murakami
  • , Michiaki Kubo
  • , Makoto Itonaga
  • , Hiroshi Handa

研究成果: ジャーナルへの寄稿 › 学術論文 › 査読

81   !!Link opens in a new tab 被引用数 (Scopus)

抄録

BACKGROUND: Although circulating exosomes in blood play crucial roles in cancer development and progression, difficulties in quantifying exosomes hamper their application for reliable clinical testing. By combining the properties of nanobeads with optical disc technology, we have developed a novel device named the ExoCounter to determine the exact number of exosomes in the sera of patients with various types of cancer. METHOD: In this system, individual exosomes were captured in the groove of an optical disc coated with antibodies against exosome surface antigens. The captured exosomes were labeled with antibody-conjugated magnetic nanobeads, and the number of the labeled exosomes was counted with an optical disc drive. RESULTS: We showed that the ExoCounter could detect specific exosomes derived from cells or human serum without any enrichment procedures. The detection sensitivity and linearity with this system were higher than those with conventional detection methods such as ELISA or flow cytometry. In addition to the ubiquitous exosome markers CD9 and CD63, the cancer-related antigens CD147, carcinoembryonic antigen, and human epidermal growth factor receptor 2 (HER2) were also used to quantify cancer cell line-derived exosomes. Furthermore, analyses of a cross-sectional cohort of sera samples revealed that HER2-positive exosomes were significantly increased in patients with breast cancer or ovarian cancer compared with healthy individuals and those with noncancer diseases. CONCLUSIONS: The ExoCounter system exhibits high performance in the direct detection of exosomes in cell culture and human sera. This method may enable reliable analysis of liquid biopsies.

本文言語英語
ページ(範囲)1463-1473
ページ数11
ジャーナルClinical Chemistry
巻64
号10
DOI
出版ステータス出版済み - 10-2018

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

  1. SDG 3 - すべての人に健康と福祉を
    SDG 3 すべての人に健康と福祉を

All Science Journal Classification (ASJC) codes

  • 医学一般

フィンガープリント

「Development of a highly sensitive device for counting the number of disease-specific exosomes in human sera」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル